Navigation Links
Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
Date:11/6/2012

SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the Lazard Capital Markets 9th Annual Healthcare Conference in New York on Tuesday, November 13, 2012 at 1:30 p.m. PT/4:30 p.m. ET. Kurt Gustafson, Chief Financial Officer, Halozyme Therapeutics, will provide a corporate overview.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

The presentation will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com, and a recording will be made available for 90 days following the event. To access the live webcast, please log on to Halozyme's website approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Halozyme
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets HYLENEX® recombinant (hyaluronidase human injection) and has partnerships with Roche, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Media/Investor Contact:
Anne Erickson
Executive Director
Halozyme Therapeutics
858-704-8264
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Halozyme to Host Third Quarter Financial Results Conference Call
2. Halozyme Reports Second Quarter 2012 Financial Results
3. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
4. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
5. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
6. Halozyme Reports First Quarter 2012 Financial Results
7. Halozyme to Host First Quarter 2012 Financial Results Conference Call
8. Novelos Therapeutics Closes $2 Million Private Placement
9. US Allows Two Key Patents for Silence Therapeutics
10. United Therapeutics Corporation Reports Third Quarter 2012 Financial Results
11. Cell Therapeutics, Inc. (CTI) Reduces Net Loss for Third Quarter and Nine Months Ended September 30, 2012 Compared to Same Periods in 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... 2014  Eli Lilly and Company (NYSE: ... non-clinical study in genetically engineered mice examining combination ... antibody N3pG and beta-secretase inhibitor BACE (LY2811376). Data ... in removing clumps of amyloid-beta protein in the ... lead to Alzheimer,s disease (AD) – than use ...
(Date:7/11/2014)... , July 11, 2014  Rock Creek Pharmaceuticals, ... company, today announced that the Food and Drug Administration ... provide comments on RCP,s Investigational New Drug ("IND") application ... trial in the US. Dr. Chris ... review and comments on our IND. When we receive ...
(Date:7/11/2014)... , July 11, 2014  Kindred Hospital ... to announce the opening of its new outpatient ... outpatient services to people with chronic, hard to ... which can lead to amputation, lower leg wounds ... have delayed closure, and traumatic injury wounds which ...
Breaking Medicine Technology:New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2
... in Akron (ABIA) and the U.S. Food and Drug ... support and develop regulatory science for the safe and ... Effective today, the FDA and ABIA executed a Memorandum ... upon ABIA resources—including a library of test methods for ...
... Fero Industries, Inc. (OTCQB: FROI), announced today ... has completed the registration process to become a ... institutions within Mexico. This license, which is the ... Company to provide coverage to PEMEX (Petroleos Mexicanos), ...
Cached Medicine Technology:FDA, Austen BioInnovation Institute to Collaborate on the Safety and Performance of Materials used in Medical Devices 2FDA, Austen BioInnovation Institute to Collaborate on the Safety and Performance of Materials used in Medical Devices 3Fero Industries, Inc. Achieves First Certified Supplier Status to Distribute Sucanon® in Mexico 2Fero Industries, Inc. Achieves First Certified Supplier Status to Distribute Sucanon® in Mexico 3
(Date:7/13/2014)... July 14, 2014 MED-Ed Facilities is ... our next conference, April 7+8 in Boston at the ... at the recent event. Presentations by individuals or teams ... To review the types of sessions that were presented ... Submit your proposal today! , Conference Director, The ...
(Date:7/13/2014)... 2014 MillionaireCasket.com is a professional supplier of ... wood caskets are selling well in the global market. Recently, ... caskets and launched a special offer for all the ... all the company’s cherry caskets are made with superb materials. ... for people to show respect to the departed saint. MillionaireCasket.com ...
(Date:7/13/2014)... York (PRWEB) July 13, 2014 Intraocular ... Trends and Forecast 2013 - 2019 , Intraocular lens ... suffering from myopia or cataracts. The lenses are inserted ... the cataract surgery intraocular lens replaces the focusing power ... with original crystalline lens to deliver the light focusing ...
(Date:7/13/2014)... July 13, 2014 Victorian Hotel has ... promoting the rental of bikes for its "Cycle the ... Victorian Hotel to tour the area using a rental ... Bicycle enthusiasts love to call Vancouver home, as it ... cycle travel and picturesque journeys through the countryside. Vancouver ...
(Date:7/13/2014)... 13, 2014 Fuel additives are chemicals, ... diesel, jet fuel, kerosene, and so on, in order ... for reducing the corrosion effects caused by fuels and ... to any fuel, provide economies of scale in the ... the overall cost of the fuel products. , The ...
Breaking Medicine News(10 mins):Health News:MED-Ed Facilities Conference Call for Speakers Open 2Health News:Brand New Cherry Caskets Unveiled By China Casket Supplier MillionaireCasket.com 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4
... 18, 2011) Scientists at the Children,s Center for ... of Children,s Hospital Los Angeles today announced a breakthrough ... They have identified a protein called CD19-ligand (CD19-L) located ... facilitates the recognition and destruction of leukemia cells by ...
... 18 (HealthDay News) -- A disease the affects your legs ... About 9 million Americans over the age of 50 ... risk for heart attack, according to the Vascular Disease Foundation ... have the condition, the foundation says. PAD occurs when ...
... Center for World Health & Medicine at Saint Louis University ... forming a global research partnership that initially will focus on ... connected by a shared commitment to fight a devastating disease, ... scientists who formerly worked together in Chesterfield, Mo. GIBH ...
... Wittig, M.D., chief of the division of skin and ... Hackensack University Medical Center will present eleven different educational ... upcoming American Academy of Orthopaedic Surgeons Conference. Dr. Wittig ... practices in limb-sparing surgery. In 2009, he and his ...
... rich plasma (PRP) to promote healing in various surgeries, ... PRP did not improve healing after rotator cuff repair. ... investigators, will be presented at the upcoming American Orthopedic ... held Feb. 19 in San Diego, Calif., following the ...
... Parents and caregivers have traditionally relied on cribs, playpens ... The massive crib recalls followed by the announcement in ... Commission (CPSC) to ban drop-side cribs have caused many ... new study conducted by researchers at the Center for ...
Cached Medicine News:Health News:Scientists bioengineer a protein to fight leukemia 2Health News:Leg Discomfort Might Signal Heart Trouble 2Health News:Saint Louis U scientists partner on malaria research 2Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 2Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 3Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 4Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 5Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 6Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 7Health News:Study shows PRP, commonly used technique to improve healing, doesn't work in rotator cuff surgery 2Health News:Study shows PRP, commonly used technique to improve healing, doesn't work in rotator cuff surgery 3Health News:New study finds 9,500 ED visits related to cribs, playpens and bassinets each year in US 2Health News:New study finds 9,500 ED visits related to cribs, playpens and bassinets each year in US 3
For Detection of Bile Component in Reflux Disease...
... With the advance of digital imaging ... advancing towards digital formats, allowing for ... This advance in digital pathology imaging ... occurred in radiology, and which is ...
... Analyzer II is a ... to enumerate fluorescently labeled ... selected and aligned. The ... CellTracks® Analyzer II, a ...
These Iron Control Slides make an excellent addition to your laboratory. Packed ten (10) control slides per box. Use SDL's Snap n' Stain for Iron Staining Kit alongside to save time an money mixing r...
Medicine Products: